Business & Decision Life Sciences was acquired by Orange.
How does this impact your business?
The Orange Group aims to be one of the world’s leaders in connected health care. Sharing this ambition, we joined them in 2018.
The impact on our offers was huge, seeing that the Orange Group added lots of expertise to ours, completing our Health Care and Life Sciences value chain, and also strengthening our image as a trustworthy multi-specialist partner in the sector.
We have kept our strong CRO know-how in Clinical Operations, Biometrics, Pharmacovigilance and Regulatory Affairs, complementing it with expertise in the clinical data journey (collection, transportation, security, storage) and Data Analytics (Big Data, Data Sciences) to turn ourselves into a CRO of choice, a true digital transformation partner.
Hence, whereas our competitors seem to have difficulties to assemble all the pieces, our offers have grown to be comprehensive, end-to-end packages with high added value.
Yoann Cotte – CEO Business & Decision Life Sciences Group
What are Business & Decision Life Sciences’ biggest challenge and main asset for the future?
Our biggest challenge?
- This would mainly be an internal issue. We need to make sure that all our employees know the company (Group) and its assets, that they know how to talk about it in away that contributes to our growth in maturity, and that creates new opportunities. Moreover, each and every one of our consultants needs to be able to enrich themselves through this growing awareness and through sharing these insights, so as to support Business & Decision Life Sciences in proposing a comprehensive, agile offer that includes all aspects of our Life Sciences expertise.
Our main asset?
- I would say that our main asset is directly inspired by the great opportunity our incorporation in the Orange Group has given us. Our service building blocks complement each other, which allows us to approach our clients from a common, inclusive vision, offering them the possibility to entrust us with their clinical studies from end to end: from data collection to valorization, transport, security,
storage, classification, interpretation … no matter its volume or its sources.
Benoit Thomas – Country Manager Belgium
How do you plan to provide new and innovative solutions to your clients?
What enables us to provide new and innovative solutions to our clients, is the perfect blend of Life Sciences and data knowledge available within Business & Decision Life Sciences and Business & Decision Consulting. We stimulate that innovation by bringing the right people together and initiating co-creation tracks, and we’re happy to share our experiences and best practices based on actual cases realized for various industry sectors.
By supporting our teams’ members in their personal development, offering the opportunity to learn, to increase and to practice their knowledge through internal initiatives of co-creation, we aim to boost the adoption of innovation by our customers.
We can deliver innovative solutions in different operating models, like consulting, project and managed services. In addition, through Managed Services, our clients can count on our support in their transition from project stage to running mode.
Jean-Noël Wallet –Director Delivery and Solution Portfolio
How do you support your pharmaceutical clients in their digital transformation?
To accompany pharmaceutical companies and laboratories in their digital transformation, we rely on our expertise, which is based on 3 pillars:
Technology & Infrastructure: Thanks to Orange, we are able to support companies throughout the Health Data Journey, from data collection to storage and transport, and to ensure that everything is done in an ultra-secure way.
Digital & Data: Our profound expertise in Big Data, Data Science, Data Governance and Digitalization, qualifies us to assist our clients in the exploitation and analysis of their data and real world evidence (RWE).
CRO: Our history as a CRO turned us into true masters in the field, with the capacity to adapt to the challenges, needs and stakes at play within the Life Sciences sector.
The synergy between our 3 pillars allows us to propose a complete and unique value chain to accompany our clients in their digital transformation.
Claire Blondel – Director Cross-functional Projects and eHealth
What efforts does Business & Decision make to retain expert consultants in this competitive market?
The key word is ‘Differentiation’. We look for differentiation in all aspects of Human Resources, hence in every step of the employee cycle, from sourcing over hiring, onboarding, career management, rewarding and beyond. This translates into initiatives such as Top Employer, a focus on the candidate journey, high attention to the follow-up of consultants, differentiation in reward package, and so on.
Steven op ’t Roodt – HR Director
You are playing in a niche sector. How do you distinguish and promote yourself?
Well, several aspects play a role here. First, we differ from other players in the market thanks to the unique Data Journey we are able to offer in collaboration with Orange Healthcare. From the collection of your data all the way up to storage and valorization through Analytics, Data Visualization, and many other solutions, Business & Decision Life Sciences can provide added value. Secondly, our staff consists of medical experts in varied fields, several of them residing as a board member of sector organizations such as CDISC and PHUSE. Finally, we care a lot about our customers and strive to give them the best possible experience. As customer intimacy is high up on our priority list, we make sure to stay in touch on a regular basis, to listen to your needs, to keep you up to date … And actually, it’s our intention to further intensify our efforts in that area.
Bjorn Andelhofs – Marketing & Communications Officer